Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.235 USD | +5.37% | -0.31% | -45.27% |
04-04 | Morgan Stanley Initiates Coverage on Mural Oncology With Overweight Rating, $13 Price Target | MT |
01-08 | Mural Oncology plc Announces Enhancements to Late-Stage Clinical Trials | CI |